Roberto Würth
Roberto Würth
Email verificata su dkfz-heidelberg.de
Titolo
Citata da
Citata da
Anno
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt
R Würth, A Pattarozzi, M Gatti, A Bajetto, A Corsaro, A Parodi, R Sirito, ...
Cell Cycle 12 (1), 145-156, 2013
1482013
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment
R Würth, A Bajetto, JK Harrison, F Barbieri, T Florio
Frontiers in cellular neuroscience 8, 144, 2014
1422014
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
M Gritti, R Würth, M Angelini, F Barbieri, M Peretti, E Pizzi, A Pattarozzi, ...
Oncotarget 5 (22), 11252, 2014
952014
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
R Wuerth, S Thellung, A Bajetto, M Mazzanti, T Florio, F Barbieri
Drug discovery today 21 (1), 190-199, 2016
932016
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity
M Gatti, A Pattarozzi, A Bajetto, R Würth, A Daga, P Fiaschi, G Zona, ...
Toxicology 314 (2-3), 209-220, 2013
912013
Peptide receptor targeting in cancer: the somatostatin paradigm
F Barbieri, A Bajetto, A Pattarozzi, M Gatti, R Würth, S Thellung, A Corsaro, ...
International journal of peptides 2013, 2013
872013
17β-Estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib …
A Pattarozzi, M Gatti, F Barbieri, R Würth, C Porcile, G Lunardi, A Ratto, ...
Molecular pharmacology 73 (1), 191-202, 2008
822008
New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells
R Würth, F Barbieri, T Florio
BioMed research international 2014, 2014
672014
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
B Banelli, E Carra, F Barbieri, R Würth, F Parodi, A Pattarozzi, R Carosio, ...
Cell Cycle 14 (21), 3418-3429, 2015
652015
In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors
F Barbieri, S Thellung, A Ratto, E Carra, V Marini, C Fucile, A Bajetto, ...
Bmc Cancer 15 (1), 1-17, 2015
502015
Cellular prion protein controls stem cell-like properties of human glioblastoma tumor-initiating cells
A Corsaro, A Bajetto, S Thellung, G Begani, V Villa, M Nizzari, ...
Oncotarget 7 (25), 38638, 2016
462016
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors
G Gaudenzi, M Albertelli, A Dicitore, R Würth, F Gatto, F Barbieri, F Cotelli, ...
Endocrine 57 (2), 214-219, 2017
422017
Balance between somatostatin and D2 receptor expression drives TSH‐secreting adenoma response to somatostatin analogues and dopastatins
F Gatto, F Barbieri, M Gatti, R Wurth, S Schulz, JL Ravetti, G Zona, ...
Clinical endocrinology 76 (3), 407-414, 2012
422012
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature
R Würth, F Barbieri, A Bajetto, A Pattarozzi, M Gatti, C Porcile, G Zona, ...
Journal of neuroimmunology 234 (1-2), 115-123, 2011
362011
Phenotypical and pharmacological characterization of stem-like cells in human pituitary adenomas
R Würth, F Barbieri, A Pattarozzi, G Gaudenzi, F Gatto, P Fiaschi, ...
Molecular Neurobiology 54 (7), 4879-4895, 2017
322017
Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA
D Costa, A Gigoni, R Würth, R Cancedda, T Florio, A Pagano
Cancer cell international 14 (1), 1-11, 2014
282014
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential
F Barbieri, R Wurth, A Ratto, C Campanella, G Vito, S Thellung, A Daga, ...
Experimental cell research 318 (7), 847-860, 2012
272012
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma
F Barbieri, A Bajetto, S Thellung, R Würth, T Florio
Expert Opinion on Drug Discovery 11 (11), 1093-1109, 2016
262016
Inhibition of the autophagy pathway synergistically potentiates the cytotoxic activity of givinostat (ITF2357) on human glioblastoma cancer stem cells
F Angeletti, G Fossati, A Pattarozzi, R Würth, A Solari, A Daga, I Masiello, ...
Frontiers in molecular neuroscience 9, 107, 2016
232016
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets
F Barbieri, R Würth, RE Favoni, A Pattarozzi, M Gatti, A Ratto, A Ferrari, ...
Biochemical pharmacology 82 (10), 1467-1477, 2011
232011
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20